Author: Purple Foxy

DoD and VA Healthcare Facilities Can Now Purchase UroViu’s Single-Use Endoscopy Products

LOS ALTOS, Calif. – October 13, 2022 – (Newswire.com)

UroViu Corp, a company that develops and commercializes highly portable single-use endoscopy platforms, announced today that it has been added to the US Defense Logistics Agency’s Medical Equipment ECAT. With a contract secured through Fidelis Sustainability Distribution, Veterans will now have access to the latest endoscopy products on the market. 

Under the agreement, UroViu will sell its entire product line at a contracted price for distribution exclusively through Fidelis to over 1,200 VA and DOD healthcare facilities throughout the United States that serve 9 million enrolled Veterans each year. 

“Urology is the second most common indication by procedure volume in the Veterans Health Administration (VHA) representing a large market for UroViu,” said Sebastien Cadet, Chief Commercial Officer of UroViu Corp. “ECAT is the most convenient and cost-effective way to deliver our products to all government facilities. It is with great pride we can now efficiently support our Veterans.”

Single-use endoscopy is a safer and more reliable alternative to traditional reusable scopes which must be cleaned, disinfected, and sanitized after every use. The difficulty of servicing traditional scopes has led to FDA scrutiny due to cross-contamination risks. UroViu’s single-use scopes eliminate those risks. The single-use platform ranges from a 12-Fr diagnostic semi-rigid cystoscope and equivalent hysteroscope, a 14-Fr injection cystoscope with an integrated needle for drug delivery, to a flexible, deflectable, and rotatable 16.5-Fr cystoscope have the potential to help any government facilities improve care and efficiency. 

“Fidelis’ SDVDSB status provides UroViu with preferential access to secure VHA and DOD contracts,” said Joel Kohn, President of Fidelis Sustainability Distribution, LLC. “More importantly, we help streamline the procurement process thus accelerating the delivery of cutting-edge technologies such as UroViu’s single-use endoscopes that our Veterans deserve.”

About UroViu Corporation

UroViu Corporation’s mission is to revolutionize the endoscopy platform for improved patient care and provider efficiency with operations in California and Washington and production facilities in Asia. UroViu is the developer of the always-ready cystoscopy & hysteroscopy platforms, the highly portable, self-contained, and versatile single-use endoscopy solution to meet the needs of Urologists, UroGynecologists, and Gynecologists. The unique portable platform and product suite are protected by a portfolio of 20+ patents granted worldwide and many more pending patents. UroViu’s vision is to simplify the scope of patient care. For more information please visit www.uroviu.com.

About Fidelis Sustainability Distribution

Fidelis Sustainability Distribution, LLC, (FSD) is a Nevada-based, Service-Disabled Veteran-Owned Small Business (SDVOSB) focused on helping streamline the acquisition of medical/dental technology in US Government facilities. Our firsthand industry experience of how technology moves from concept to commercialization and through healthcare supply chains enables us to support our manufacturing partners and Government customers alike at the highest level. Since 2014, FSD has secured over $80M+ in positive past performance and is dedicated to serving all major Federal Healthcare facilities including 170+ VAMC’s, 1,000+ CBOC’s,150+ DOD Medical Facilities, and Health and Human Services (HHS).

Contact Information:

Lisa Sorbo

Marketing Manager, UroViu Corp

lisa@uroviu.com

941-667-0043

Press Release Service
by
Newswire.com

Original Source:

UroViu Corp Secures Medical Equipment ECAT Contract for VA DoD Purchasing

Dr. Andrea Small-Howard discusses the company’s novel process for developing disease-specific, cannabinoid-based therapeutics.

LAS VEGAS – October 13, 2022 – (Newswire.com)

Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, is demonstrating the potential efficacy of their proprietary cannabis-inspired mixtures today at the Canna Pharma 2022 Conference in San Diego, California. Dr. Small-Howard explains Gb Sciences’ novel process for developing disease-specific, cannabinoid therapeutics in her presentation entitled “Case Studies: Identification of Minimum Essential Therapeutic Mixtures from Cannabis Plant Extracts by Screening in Cell and Animal Models.” Gb Sciences’ case studies include scientific evidence demonstrating the potential efficacy of their cannabinoid-based therapeutic mixtures designed to treat Parkinson’s disease, chronic pain, or inflammation using their novel minimal essential mixture approach.

“Medicinal cannabis has shown great promise for the symptomatic treatment of many serious human disorders, but concerns around safety, consistency, legality, psychoactivity, and non-standardized routes of delivery, such as smoking and vaping, have slowed the adoption of the use of medical cannabis within traditional, physician-guided patient treatment programs. To address these challenges, we hypothesized that within Cannabis plant extracts, there would be a minimal essential mixture of compounds that preserves whole plant benefits, but with the manufacturing, quality control, and regulatory benefits of single ingredient therapies,” said Dr. Andrea Small-Howard.

Minimal essential mixtures (MEM) is a term Gb Sciences has coined from their proprietary research after deeming that a simplified mixture represented a happy medium between whole plant medicines and single ingredient drugs. Minimum Essential Mixtures are designed to retain increased therapeutic effectiveness from molecular synergies within the original plant extracts, but with the manufacturing efficiencies, quality assurances, and regulatory advantages of single ingredient drugs. Gb Sciences’ disease-specific MEM are produced for clinical evaluation using synthetic homologs of cannabis-based ingredients incorporated into sophisticated oral delivery modalities including Oral Dissolving Tablets (ODT), Oral Thin Films (OTF), time-released oral nanoparticles, and gel capsules to increase the stability, bioavailability, and ease-of-use of these ingredients relative to the non-standardized delivery methods used for Cannabis plant extracts.

Gb Sciences was recently published in Pharma’s Almanac discussing the strategy behind their plant-inspired minimum essential mixtures, which provides context for the case studies being presented today.

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The ‘plant-inspired’ active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences’ intellectual property portfolio contains six issued U.S. and three issued foreign patents, as well as 17 U.S. and 51 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences’ lead program for Parkinson’s disease is being prepared for a first-in-human clinical trial. Gb Sciences’ formulations for chronic pain, anxiety, and depression are currently in preclinical animal studies with researchers at the National Research Council Canada. The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences’ productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com. 

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:

Madeleine Moench

madeleine@newswire.com

Press Release Service
by
Newswire.com

Original Source:

TODAY: Gb Sciences’ President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference

Will Be the Only Provider in King County Awarded the Competitive Grant

TUKWILA, Wash. – October 12, 2022…

RIVERDALE, N.Y. – October 12, 2022 – (Newswire.com)

RiverSpring Living’s Hebrew Home at Riverdale, the iconic Bronx-based long-term care community, announced today a major push into technology with an expansive augmented and virtual reality initiative for its 600+ residents.

Residents of the Hebrew Home at Riverdale are experiencing a new virtual reality program through a partnership with Boston-based Rendever. Rendever, a leading provider of virtual reality services to the healthcare industry, has created a custom VR experience for the Hebrew Home community, transporting older adults around the world.

This VR effort is making the impossible possible. The limitations of age and physical fragility, in addition to the impact of COVID, has reduced and, in many cases, prevented residents of the Hebrew Home from traveling outside of the campus. Virtual reality has opened the doors of possibility to change that. 

This technology is being used in a variety of initiatives:

Globetrotting Near and Far

Residents are being transported to the Eiffel Tower, the Great Wall of China and to the neighborhoods where they grew up. Because of technology, there is no limitation to where and when they can explore.

Attending Family Gatherings … Virtually

The Hebrew Home is equipping family members of its long-term care residents with GoPro cameras to film weddings, graduations, little league games and other important family events and gatherings.  

Footage is uploaded to the VR headsets and shared with residents. Trained therapists work with residents, talking about the meaning of the family event, how they feel, and memories of spending time with them when they were younger.  

Easing the Agitation of Dementia

Preliminary usage of VR at the Hebrew Home indicates that residents suffering from early stages of dementia are engaged and demonstrate increased attention and decreased agitation when using VR headsets that display family or calming images.

Preparing for Home After Rehab

Families of rehab patients are provided GoPro cameras to film each room in the home.  These videos are uploaded to a virtual reality headset so that the patient can virtually walk through each room. Therapists can see the room on an accompanying iPad, helping the patient navigate. If changes need to be made — such as removing rugs to prevent falls, opening more space between a couch and table for a walker or wheelchair to get through, the therapist provides feedback before the patient heads home.

Augmented and virtual reality is creating worlds to see and meet people beyond the Hebrew Home’s Riverdale campus. With this new technology initiative, Hebrew Home residents are just a headset away from endless possibilities.

About RiverSpring Living

RiverSpring Living, backed by over 100 years of top-rated service as the Hebrew Home at Riverdale, provides progressive care to over 18,000 older adults of all faiths through compassionate care and vibrant community engagement, and is guided by Jewish values and a non-profit mission that advocates and celebrates a vision of empowered aging.

Contact:  
Wendy Steinberg 
718-581-1253 / 347-988-4446

Contact Information:

Wendy Steinberg

Vice President of Communications

wendy.steinberg@riverspring.org

718-581-1253

Press Release Service
by
Newswire.com

Original Source:

RiverSpring Living’s Hebrew Home at Riverdale Announces Major Focus on Augmented and Virtual Reality Initiatives to Enhance Quality of Life for Its Residents

Affiliation marks continued growth for Great Expressions in the Northeast

SOUTHFIELD, Mich. – October 12…

Signs New Distribution Partners in Three Countries

LAWRENCEVILLE, Ga. – October 12, 2022 …

Expansion exemplifies the company’s commitment to meet the highest security and compliance standards

TORONTO – October 12, 2022 – (Newswire.com)

Smile CDR Inc. (doing business as Smile Digital Health), a leading health data and integration company, today announced it has passed an Amazon Web Services (AWS) Foundational Technical Review (FTR) and has achieved Amazon HealthLake (AHL) Connector partner status in the AWS Partner Network (APN). Healthcare organizations can expect Smile Digital Health running on AWS to provide a best-in-class data fabric platform along with the confidence that it is meeting various regulatory and compliance requirements in the U.S. and the EU when storing and sharing their sensitive health data via the platform. Smile Digital Health first announced its work with AWS in March, and this expansion represents the continual growth of that relationship.

“Our ongoing work with AWS demonstrates the deep collaboration between our companies, delivering the many benefits of the Smile Digital Health data fabric platform running in a world-class hyperscale environment. Having partner status provides our customers with substantial benefits including additional security, dependability and operational excellence,” said Duncan Weatherston, Chief Executive Officer, Smile Digital Health. “Healthcare organizations — and in turn their patients — are well served by access to our scalable, high-performing, resilient and efficient data fabric platform on the leading cloud infrastructure.”

The expansion and scope of work includes two key elements:

• Becoming an Amazon HealthLake (AHL) Connector Partner, demonstrating the company’s ability to help transform existing healthcare data in real time into the required format, including standard Fast Healthcare Interoperability Resources (FHIR^®) format, so the data can be used across AHL applications and services.
   
• Passing the AWS Foundational Technical Review (FTR), which helps identify and mitigate technical risks in solutions built by independent software vendors (ISVs). Smile Digital Health’s solutions were evaluated by a subset of AWS Well-Architected best practices. As part of the review, Smile Digital Health’s reference architecture was approved to be deployed on Amazon Elastic Kubernetes Services (Amazon EKS), a managed container service to run and scale Kubernetes applications in the cloud or on-premises, and Amazon Aurora and Amazon Relational Database Service (Amazon RDS) for PostgreSQL to ensure a performant, cost-effective, secure and scalable solution.

“Our customers can expect Smile Digital Health to continuously meet and often exceed regulatory and compliance requirements when storing and sharing their sensitive health data via our data fabric platform. In that sense, we continue to guarantee the highest security and compliance standards,” said James Agnew, Chief Technology Officer, Smile Digital Health.

Smile Digital Health’s work on AWS continues to simplify the interoperability process between various data platforms, allowing for better health journey outcomes between patients, providers and health systems, and reducing information technology barriers.

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, health data fabric and exchange platform fuels healthcare’s digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate, and meaningfully share health information to power digital transformation. We prepare healthcare providers, payers, researchers, and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. We help healthcare organizations confidently #ChooseOpenStandards with the goal of #BetterGlobalHealth. For more information, visit SmileDigitalHealth.com.

Contact Information:

Lucy Railton

Director of Marketing

lucy@smilecdr.com

(800) 683-1318

Press Release Service
by
Newswire.com

Original Source:

Smile Digital Health Expands Work on AWS

Hurricane Ian’s Impact on Direct-to-Consumer Pharmaceutical Fulfillment Exacerbates an Already Vexing Challenge.

MADISON, Wis. – October 12, 2022 – (Newswire.com)

TEC Mailing Solutions, LLC, launches new service to improve the deliverability of life saving, direct-to-consumer pharmaceuticals to track the changes of new mover data.

Just like the waves of an ocean, the population continues to ebb and flow nationally at the rate of thousands of people per day. The migration has been steadily building in Fort Myers for the last decade and now the flow is retracting, as thousands of misplaced households are on the move in a small region. 

No matter how or which way the population flows, it is creating new challenges for cadence-based shippers, those fulfilling subscriptions and more importantly life-saving prescriptions. Residents of Fort Myers who were receiving their medications through the mail will be unable to obtain vital packages. 

The best data source to track new residences and address changes is the USPS National Change of Address database, which maintains move update information for the prior 48 months. Providers like TEC Mailing Solutions have unique features for the pharmaceutical industry that apply to anyone who has moved and filed a change of address with the postal service.

“We’ve been tracking live return data from our Pharmaceutical clients and effectively implementing safeguards to ensure our clients enjoy the best deliverability,” explains President Brian Euclide, President of TEC Mailing Solutions. “Returns due to change of address is a billion-dollar problem. This is a challenge we’re honored to solve.”

There will be lessons learned from IAN. Data will reveal the scale of devastation. Thankfully, there is new thinking and technology from private industry taking these challenges head-on. TEC Mailing’s Verify & Confirm™ product stops orders and packages from going to vacant or abandoned homes, buildings and people who have recently moved. Verify & Confirm™ also finds the current address of those who have filed a change of address. TEC Mailing ensures that each address is not only correct and complete but also current, in a first-of-its-kind implementation, specifically for direct-to-consumer pharmaceutical fulfillment.

About: TEC Mailing Solutions LLC is a Software as a Service (SaaS) provider of name, address hygiene, bulk mail and parcel sortation services for web-to-print, CRM, OEM, ERP, and variable digital printing solutions. TEC Mailing’s services are embedded functions in applications to improve workflow or standalone web portals: MailListCleaner®, MailPreparer™, MailPieceTracker™, ParcelPrep™, and Verify & Confirm are available direct or through a network of resell/referral partners and VARs. Privately held, the corporate office is in Sun Prairie, Wisconsin. Find more information at http://www.tecmailing.com or call 866-379-9437.

Contact Information:

Scott Eganhouse

VP

seganhouse@tecmailing.com

16082175515

Press Release Service
by
Newswire.com

Original Source:

TEC Mailing Solutions’ New Service Addresses Direct-to-Consumer Fulfillment Challenges

Designee builds on commitment to furthering excellence in the healthcare sector’s information security and privacy programs

PORTLAND, Ore. – October 12, 2022 – (Newswire.com)

Apgar & Associates, LLC today announced that it is designated as a HITRUST Readiness Licensee. With this achievement, Apgar & Associates is approved by HITRUST to perform consulting and readiness work for organizations looking to adopt the HITRUST CSF or prepare for their first assessment. For over a decade, the consultancy has provided information security and privacy services that encompass strategic planning for risk management and compliance programs, as well as consulting on security incidence response, risk analysis, and policy and procedures. 

HITRUST Readiness Licensees help uphold information security and privacy standards for various industries of varying size and complexity by assisting clients with the adoption of the HITRUST CSF framework, implementation, and remediation efforts following adoption, and facilitated self-assessments.

“We’re very pleased to receive the HITRUST Readiness designation. It feels like a natural progression in our firm’s commitment to furthering excellence in the healthcare sector’s information security and privacy programs,” stated Julia Huddleston, CIPP/US, CIPM, CCSFP, and Principal Consultant at Apgar & Associates, LLC. “We look forward to helping guide healthcare providers and their business associates through the what and how of readying for the HITRUST assessment.”

“Readiness Licensees meet the criteria to become trusted and independent resources for clients needing to improve their security posture,” said Matthew Datel, Director, Education & Strategic Initiatives at HITRUST. “Readiness Licensees are helpful in providing qualified third-party reviews for clients preparing for or seeking HITRUST CSF Certification.”

About Apgar & Associates

The consultancy’s information security and privacy services encompass strategic planning for risk management and compliance programs, as well as consulting on security incidence response, risk analysis, and policy and procedures.

The team also helps organizations decide which of the various industry certifications aligns best with the business’ privacy and information security strategy. For more information about Apgar & Associates’ consulting services, such as HITRUST Readiness, please contact the company at 503-384-2538 or visit its website at https://apgarandassoc.com/.

Contact Information:

Nora Haile

Marketing Consultant

nora@nhaile.com

520-425-6498

Press Release Service
by
Newswire.com

Original Source:

Apgar & Associates Achieves HITRUST® Readiness Licensee Designation

The agreement brings together two industry leaders, leveraging complementary strengths to enhance support of doctors in building successful dental practices. This new education platform is called Group Dentistry Instit…